CDKN1A and ovarian carcinoma: Finally, to examine whether miR-572-mediated suppression of SOCS1 and p21 in ovarian cancer is clinically relevant, seven freshly collected ovarian cancer samples and two normal ovarian tissues were obtained for further study.